Hiconcil

Quick links to important sections

Hiconcil

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hiconcil

Hiconcil is a trade name for a medicine whose single active ingredient is Amoxicillin, which is classified as a semi-synthetic antibiotic. This medication belongs to the penicillin family, specifically the aminopenicillin subgroup, and is used to kill susceptible bacteria. Its classification as a beta-lactam antibiotic defines its highly targeted and effective mechanism against microbial threats.


Quick Facts: Hiconcil (Amoxicillin)

Property Description
Active Ingredient Amoxicillin
Form Capsules, Tablets, Oral Suspension
Pharmacological Class Beta-lactam Antibiotic (Penicillin)
Common Use Treating Bacterial Infections
Origin Semi-synthetic

What Type of Medicine is Hiconcil? (Identity and Classification)

Hiconcil is a bactericidal medication, meaning its function is to actively destroy bacteria rather than merely halting their growth. The Amoxicillin component is a semi-synthetic derivative, a structural characteristic that contributes to its broad spectrum of activity, enabling it to target a wide variety of bacterial pathogens that cause infections in the human body. As a single-ingredient product, its therapeutic application is focused directly on the activity of Amoxicillin alone. The Amoxicillin structure allows it to maintain activity against numerous organisms.


Composition and Available Forms of Hiconcil (Formulation and Substance)

The active substance in Hiconcil is Amoxicillin, combined with pharmaceutical excipients to create stable dosage forms for simple, oral administration. Hiconcil is typically available in forms designed for ingestion, including capsules, tablets, and a dedicated oral suspension formulation. The availability of a liquid oral suspension makes the drug particularly adaptable for pediatric and other patient groups where swallowing solid forms may be challenging, ensuring the consistent delivery of the active agent. This flexibility in oral forms is standard for essential penicillins.


Hiconcil’s General Therapeutic Purpose and Action Principle (Benefit)

The general therapeutic purpose of Hiconcil is to resolve active bacterial infections by eliminating the causative microorganisms. This is achieved because Amoxicillin interferes with the process bacteria use to construct their protective cell walls, specifically by inhibiting the necessary transpeptidases. This highly specific mechanism ensures that Hiconcil provides a robust solution for clearing microbial infections that are sensitive to this class of medication. For instance, its utility is often noted in addressing common respiratory or skin infections caused by susceptible bacteria.

Regulatory References

  1. Amoxicillin: MedlinePlus Drug Information

What side effects are possible with Hiconcil?

Possible side effects and safety information

The official safety profile for Hiconcil (Amoxicillin) is structured by regulatory bodies based on documented incidence and impact on physiological systems. Reactions are categorized by frequency, differentiating between expected events and very rare, clinically significant effects.


Frequency-Classified Adverse Reactions

Adverse events are documented in official prescribing information based on their reported incidence rates:

Classification Examples of Reactions
Common (e.g., ge 1/100) Diarrhea, Nausea, Skin rash.
Uncommon (e.g., ge 1/1,000) Vomiting, Urticaria, Pruritus.
Very Rare (e.g., < 1/10,000) Reversible blood disorders (e.g., leucopenia, thrombocytopenia), Hepatitis and cholestatic jaundice, Severe cutaneous reactions (e.g., SJS, TEN, DRESS), Anaphylaxis, Interstitial nephritis, Convulsions.

System-Organ-Class Safety Groups

Adverse reactions are formally grouped by the system affected, including Gastrointestinal Disorders, Skin and Subcutaneous Tissue Disorders, Blood and Lymphatic System Disorders, Nervous System Disorders, and Hepatobiliary Disorders.

Serious Adverse Reactions and Safety Notes

The regulatory profile highlights serious but Very Rare adverse reactions such as Anaphylaxis (a severe allergic reaction) and Severe Cutaneous Adverse Reactions (SCARs). Concerns related to Antibiotic-associated colitis (e.g., CDAD) and Drug-Induced Enterocolitis Syndrome (DIES), which is predominantly reported in pediatric patients, are also documented.

Specific safety considerations are noted for certain populations. Patients with renal impairment may be susceptible to convulsions, and dose adjustment is formally required in severe cases. Individuals with infectious mononucleosis have a high likelihood of developing a non-allergic skin rash upon administration.

Overdose and Emergency Response

Overdose and when to seek help

The information in this section reflects the officially documented overdose manifestations and emergency actions mandated by government regulatory authorities.

Overdosage of Hiconcil (Amoxicillin) commonly presents with gastrointestinal effects including nausea, vomiting, and diarrhea. However, regulators also document more serious risks, particularly with the ingestion of very high doses or in patients with impaired renal function.

Documented Overdose Manifestations and Risks

System Affected Manifestation / Serious Outcome
Gastrointestinal Nausea, Vomiting, Diarrhea, Fluid and Electrolyte Disturbance
Renal Crystalluria (crystals in urine), potentially leading to Acute Renal Failure
Central Nervous System Convulsions (seizures)

Required Emergency Actions

The regulatory guidance strictly mandates that individuals seek immediate medical attention or emergency medical treatment if an overdose is suspected or confirmed. Regulators also advise contacting a poison control center immediately. In severe cases involving loss of consciousness, a seizure, or trouble breathing, emergency services must be called.

No specific antidote is known for Amoxicillin overdosage. Treatment focuses on symptomatic and supportive measures. In severe cases, the drug may be removed from circulation by hemodialysis, a procedure documented in regulatory prescribing information for managing high drug levels, especially when renal failure is a concern.

Therapeutic Uses of Hiconcil

Hiconcil is applied across domains where additional symptomatic support is needed for infections. This medicine is commonly used across conditions presenting with acute episodes. It helps address groups of symptoms that may appear suddenly or intensify temporarily, particularly in the context of infections affecting the ear, nose, throat, lower respiratory tract, genitourinary tract, or skin.

Relief from Acute Symptom Clusters

This treatment is often used when symptoms intensify and supportive relief is needed, contributing to easing the overall symptom load during an acute episode. It is relevant in clinical settings marked by temporary physiological imbalance where symptoms create noticeable interference with daily comfort. Supportive relief may help patients cope more steadily with symptom fluctuations.

Quick Fact: Relief for Heightened Symptoms

Hiconcil supports patients during difficult episodes by easing distress and assists with maintaining functional stability when symptoms create noticeable physiological strain.

Eligibility and Restrictions for Use

Who Can and Cannot Use Hiconcil?

Eligibility for Hiconcil (Amoxicillin) is strictly defined by official regulatory documents, focusing on patient hypersensitivity and underlying health conditions.


Absolute Contraindications

The medicine is strictly contraindicated in patients who have a known history of a serious hypersensitivity reaction, such as anaphylaxis, to amoxicillin or to any other beta-lactam antibiotic, including other penicillins and cephalosporins.


Populations with Conditional or Restricted Use

Use is generally established for adults and pediatric patients aged 3 months and older. However, specific populations are restricted:

  • Infectious Mononucleosis: The medicine is not recommended for patients with or suspected of having mononucleosis, due to the high risk of an associated non-allergic skin rash.
  • Severe Renal Impairment: Patients with severe renal impairment (GFR less than 30 mL/min) must use the medicine with conditional restrictions. The 875 mg strength is generally prohibited, and other forms require dosage modification due to delayed drug clearance.
  • Pregnancy and Lactation: Use during pregnancy (FDA Category B) is advised only if clearly needed. Nursing mothers must use caution as the drug is excreted in human milk.
  • Older adults also require caution due to the likelihood of age-related decreased kidney function.

What should I know about interactions with other medicines?

The official regulatory profile for Hiconcil (Amoxicillin) defines its interactions across several pharmacokinetic and pharmacodynamic domains. Probenecid is a specific medicine documented to interact by inhibiting the renal tubular secretion of Amoxicillin. This transporter-mediated effect results in increased and prolonged blood levels of the antibiotic, an alteration in drug exposure.

Interactions involving co-administration with other drug classes are also noted in the regulatory labeling. Concomitant use with Oral Anticoagulants may increase the prolongation of prothrombin time (INR). When administered with Allopurinol, the incidence of developing a rash is increased. Amoxicillin may also reduce the efficacy of combined Oral Contraceptives (estrogen/progesterone) by altering intestinal flora, which can affect estrogen reabsorption.

Other agents such as Chloramphenicol, Macrolides, Sulfonamides, and Tetracyclines—known as bacteriostatic antibacterials—may interfere with the bactericidal effects of penicillin, demonstrated in vitro, though the clinical significance is not fully documented by regulators. No formal drug-drug contraindications are listed in the official label interaction sections. Furthermore, no clinically significant interaction with food is documented, and the medicine may be taken with or without a meal. Exposure considerations also exist for specific populations: the risk of increased blood levels is higher in patients with impaired renal function due to decreased drug clearance.

Mechanism of Action

Hiconcil ( Amoxicillin) exerts its effect by targeting the Penicillin-Binding Proteins ( PBPs)—enzymes essential for building the rigid structural layer, or peptidoglycan, of the bacterial cell wall. The drug acts as an irreversible covalent inhibitor, binding permanently to the PBP active site. This mechanism prevents the critical cross-linking of the cell wall structure, initiating the cascade of cellular breakdown. The structural failure caused by PBP inhibition leads directly to the complete collapse of the bacterial cell's integrity. The microbe can no longer withstand its own high internal osmotic pressure, causing the cell to rupture rapidly in a process called osmotic lysis. This cascade is the mechanism that produces the bactericidal (cell-killing) physiological effect, contributing to the elimination of susceptible pathogens. However, the mechanism's functional scope is limited by the bacterial production of beta-Lactamase enzymes. These enzymes chemically destroy Amoxicillin by hydrolyzing its core beta-lactam ring, rendering the molecule unable to bind to and inactivate the PBPs. This microbial counter-mechanism defines the scope of the drug’s mechanism of action against different bacterial strains.

Dosage and Administration Information

Hiconcil is administered primarily through the oral route, utilizing dosage forms such as capsules, tablets (500 mg, 875 mg), and oral suspension. The medication is classified under administration by frequency, typically prescribed for use two or three times daily (every 12 hours or every 8 hours) to maintain consistent active substance levels. Standard adult dosing usually ranges from 750 mg to 1750 mg per day in these divided doses, with the 875 mg tablet often reserved for use in treating severe infections.

The proper administration conditions state that Hiconcil is generally well-absorbed and can be taken with or without food; however, taking it at the start of a meal may help minimize gastrointestinal effects. Specific administration rules apply to certain formulations: for instance, the powder for oral suspension requires reconstitution with water and must be measured using a calibrated device.

The course of treatment defines the duration of use. For infections caused by Streptococcus pyogenes, the full course must be completed for a minimum of 10 consecutive days. Furthermore, dose adjustments are required for specific populations. Patients with severe renal impairment require a dose reduction, and the 875 mg dosage strength is not recommended for this group. In cases of a missed dose, the general rule is to skip the forgotten dose if it is almost time for the next scheduled dose, thereby avoiding a double dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hiconcil

The research into Hiconcil (Amoxicillin) for conditions such as Acute Otitis Media (AOM) and streptococcal pharyngitis was studied for many years. This evidence comes from Randomized Controlled Trials (RCTs) and Systematic Reviews that have been examined in scientific literature. The research primarily explored the use of Hiconcil in pediatric patients (infants and young children) and adults. Studies monitored outcomes related to physical discomfort and systemic or functional imbalance, such as the measured change in fever and ear pain, and the disappearance of specific bacteria.

Evidence for Use in Lower Respiratory Tract Infections

Hiconcil was studied for respiratory illnesses, particularly Community-Acquired Pneumonia (CAP), through various RCTs and Meta-analyses. These studies examined different patient groups, including both adults and children, and often segmented findings by disease severity. The reported findings indicate patterns related to the monitored clinical endpoints in the observed populations, such as time to clinical stability. Comparative evidence is lacking for direct head-to-head trials against all newer generation antibiotics in the same class, and the results apply only to the populations studied.

Evidence for Use in Combination Therapy

The research on Hiconcil was evaluated in the context of infections such as those caused by Helicobacter pylori. Studies focused on adults and the primary outcome researched examined was microbial eradication and the secondary outcome of gastric ulcer recurrence rates. The data show patterns related to the successful clearance of the bacterium, contributing to the evidence base for standard combination protocols.

Research Limitations

Data for certain groups remain insufficient when compared to the general adult population, especially for pregnant or breastfeeding individuals, and limited information for long-term outcomes exists. The available follow-up durations were limited to the acute treatment window, meaning research does not determine whether an individual will respond similarly over an extended time frame.

Key Studies & References

  1. Label: AMOXICILLIN capsule - DailyMed (FDA-mandated Labeling)
  2. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024 Update)

Frequently Asked Questions (FAQ)

Common questions about Hiconcil (FAQ)


Q: Is Hiconcil effective for treating infections caused by viruses like the common cold or flu?

Hiconcil is classified as an antibacterial drug, meaning its function is specifically to eliminate susceptible bacteria. Official product information states that antibacterial drugs are not effective against infections caused by viruses, such as the common cold or influenza.


Q: How quickly does Hiconcil begin to work after starting treatment?

Pharmacological data indicates the active ingredient, Amoxicillin, reaches peak concentrations in the blood approximately one hour after an oral dose. The medication is concentrated enough to begin its cell-killing action on the bacteria quickly, typically within the first few hours of starting treatment.


Q: How soon after starting Hiconcil should a person expect to notice improvement in symptoms?

Based on official patient information, individuals may begin to notice improvement in their symptoms within 24 to 72 hours (two to three days) after beginning the medication. Official administration instructions define the complete duration of the medication course, which is to be followed regardless of the speed of symptom improvement.


Q: What is the difference between Hiconcil (amoxicillin) and regular penicillin?

The active ingredient in Hiconcil is a semi-synthetic derivative of the penicillin family, meaning it shares a core structure with older penicillins. It is described as having similar antibacterial activity but is observed to have a higher degree of absorption when taken orally, allowing it to achieve higher concentrations in the bloodstream.


Q: How does Hiconcil differ from amoxicillin in combination with clavulanate (co-amoxiclav)?

Hiconcil alone is susceptible to being chemically destroyed by beta-Lactamase enzymes that some bacteria produce. The combination product contains an additional medicine (clavulanate) specifically intended to protect the Amoxicillin from being broken down by these enzymes. This protective action can expand the range of bacteria the antibiotic can target.


Q: Is a mild skin rash always a sign of an allergy to Hiconcil?

A skin rash is not always indicative of a serious allergy to the medicine. Official documentation specifically notes that patients who have infectious mononucleosis (a viral infection) are highly likely to develop a non-allergic rash when taking Amoxicillin.


Q: Why do some people develop oral thrush or a yeast infection after a course of Hiconcil?

The medication can sometimes disrupt the body's natural balance of flora, which can allow for the overgrowth of non-susceptible organisms, such as fungal pathogens like Candida. This overgrowth is referred to as a superinfection and can manifest as oral or vaginal thrush.


Q: Is Hiconcil associated with any effects on the liver?

The regulatory safety profile lists liver-related reactions, specifically hepatitis and cholestatic jaundice, as very rare adverse effects. Official guidance includes the consideration of periodic assessment of hepatic function (liver health) during prolonged therapy.


Q: Is it generally safe to consume alcohol in moderation while taking Hiconcil?

Official regulatory documentation and patient leaflets do not list a clinically significant interaction or contraindication between Hiconcil and alcohol.


Q: What is the usual length of a Hiconcil treatment course?

The length of a Hiconcil treatment course is determined by the specific infection being treated and is not a fixed duration. Official prescribing information defines the duration according to the diagnosis; for example, a course for strep throat is noted as a minimum of 10 consecutive days.


Q: Are there any herbal supplements that are known to interact with Hiconcil?

Official health authorities indicate that there is generally insufficient information regarding the safety of taking herbal remedies or supplements concurrently with the medication. This is because these products are typically not subjected to the same standardized interaction testing as prescription medicines.


Q: Can Hiconcil affect a person's ability to drive or operate machinery?

Official information states that the medicine does not affect the ability to drive or use heavy machinery. However, the safety profile classifies adverse events such as neurological disorders, and the potential for these rare events is noted in the official profile.


Q: Does Hiconcil liquid suspension have any known effect on tooth color or temporary staining?

There have been reports of temporary tooth discoloration (yellow, brown, or gray) associated with the liquid suspension form of the medicine. Official information describes this staining as non-permanent and generally removable with brushing or professional dental cleaning.


Q: Can Hiconcil interfere with the results of certain laboratory tests, such as urine sugar tests?

The medication may interfere with the results of certain laboratory tests. This includes the potential to cause a false-positive result when testing for glucose (sugar) in the urine.


Q: What kind of infections will Hiconcil not be able to treat?

The medication is not effective against infections caused by viruses, such as the common cold or flu. It is also ineffective against bacterial strains that produce the beta-Lactamase enzyme, which can destroy the active ingredient.


Q: What are the warning signs of a serious bowel condition, like Clostridium difficile, that can follow Hiconcil use?

The regulatory safety information highlights the risk of a serious complication called Antibiotic-associated colitis (e.g., Clostridium difficile). Symptoms to consider include persistent, watery or bloody diarrhea, fever, or severe, persistent stomach pain that occurs during or even after the course of the antibiotic.


Q: What is the difference between a common side effect and an allergic reaction to Hiconcil?

An allergic reaction is an immune system response that can cause severe symptoms like anaphylaxis (a potentially life-threatening reaction), hives, or swelling. A common side effect, such as diarrhea or nausea, is a non-immune adverse event listed with a high frequency in the official safety profile.


Q: Are there any reported neurological effects that have been associated with Hiconcil?

Neurological effects, specifically convulsions (seizures), are documented as a Very Rare adverse reaction. This reaction is particularly noted in official safety information for patients with impaired kidney function or those receiving very high doses.


Q: What kind of research evidence supports the approved uses of Hiconcil?

Studies and research evidence have been examined in official documents relating to its use in conditions like Acute Otitis Media, streptococcal pharyngitis, and Community-Acquired Pneumonia. Research has also been evaluated for its use in combination therapy for Helicobacter pylori eradication.


Q: How is the safety profile of Hiconcil generally described in medical literature for approved uses?

The official safety profile generally describes most reactions as Common (such as diarrhea and nausea) based on reported incidence rates. It also documents other reactions as Very Rare, including severe events like anaphylaxis and severe cutaneous reactions.


Q: Is it appropriate to take over-the-counter anti-diarrhea medication if Hiconcil causes loose stools?

Official warnings and safety notes indicate that the use of over-the-counter anti-peristaltic products (medicines that slow the gut) is not recommended. This is because the diarrhea could be a symptom of a serious complication like Antibiotic-associated colitis. Diarrhea that is persistent or severe is noted in official information as requiring further medical attention.

How should Hiconcil be stored and disposed of?

Storage and Disposal Requirements for Hiconcil (Amoxicillin)

The storage requirements for Hiconcil are dependent on the medication form, and all instructions must be followed to ensure the product's stability and efficacy.


Storage Conditions

Dry Product (Capsules, Tablets, Powder): Must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Keep the product in its tightly closed original container and protect it from moisture.

Reconstituted Oral Suspension: Requires storage in a refrigerator at 2 C to 8 C (36 F to 46 F) and must not be frozen. The liquid suspension must be discarded after 14 days.


Safety and Disposal

The medicine must be stored out of the sight and reach of children. Unused or expired Hiconcil must be disposed of by following local government regulations. Do not dispose of the medication via wastewater or household trash unless specifically directed by an authorized collection program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hiconcil found in:

A-Z Index: